Now in its 18th year, SCOPE returns March 1–4, 2027, in Orlando, bringing together 5,000+ clinical research professionals from 1,200+ organizations across 30+ countries. With 38 conference tracks, 4 plenary keynote sessions, and 325+ exhibiting companies, SCOPE explores the critical issues shaping the future of clinical research, from trial design, patient recruitment and site engagement to RWD/RWE, AI, clinical development strategy and operations, and ClinTech investment. Join a vibrant, collegial community where the entire clinical research ecosystem comes together to share ideas, build relationships, and do business.
MONDAY, MARCH 1, 2027
Co-locate your User Group, Workshop, or even your company’s Annual Meeting with SCOPE Summit: www.scopesummit.com/scope-user-group-meetings
8:00 am SCOPE’s 6th Annual Masters of Clinical Research Golf Tournament* (Sponsorship Opportunities Still Available)
Network on the greens at SCOPE's 6th Annual Golf Tournament! Visit the SCOPE website for player and sponsorship opportunities.
*Limited space available. Must be registered for SCOPE. Separate registration and fee required.
9:00 am Registration Open
1:00 – 3:45 pm SCOPE'S Pickleball Networking Session: Paddles & Partnerships
Kick off the SCOPE 2027 conference with food, fun, and pickleball! Whether you're a pickleball pro or have never picked up a paddle, this event is perfect for everyone. Limited spots available. See the Workshops & User Groups page for details.
1:00 – 3:00 pm Evinova Workshop
See the Workshops & User Groups page for details.
1:00 – 3:30 pm IQVIA Innovation Day
See the Workshops & User Groups page for details.
1:00 – 3:30 pm MAXIS AI Workshop
See the Workshops & User Groups page for details.
3:40 pm Grab Your Seat: Early-Bird Seat Golden Ticket Raffle & Prize Giveaway*
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
*Must be present to win.
3:45 pm Organizer's Welcome Remarks & 6th Annual Masters of Clinical Research Golf Tournament Awards and Jacket Signing
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
3:50 pm Chairperson's Introduction: From Innovation to Impact: Redefining the Modern Clinical Trial Site
Tyler Van Horn, CEO, Science 37
3:52 pm KEYNOTE INTERACTIVE PANEL: SCOPE's 4th Annual Site Innovation Awards
PANEL MODERATORS:
Irfan Khan, CEO, Circuit Clinical
Amanda Wright, Co-Founder & COO, Javara
We are excited to announce the 4th Annual Site Innovation Award, recognizing sites and partnerships pioneering new approaches to improve clinical trials. Showcase your success, gain recognition from your peers, and share actionable solutions with the SCOPE Clinical Operations community. Innovation can be low- or high-tech, or any site operations improvement that reduces burden, advances research, and supports patient-centered care. Submit your proposal: /site-innovation-award
PANELISTS:
Karen Correa, PhD, Vice President, Development Operations, Boehringer Ingelheim
Angela DeLuca, Associate Vice President, Global Study Operations, Amgen
Joe Dustin, Senior Director, Digital Clinical Development, Sanofi
Sean Soth, Senior Vice President, Strategy and Global Business Partnerships, SCRS
4:13 pm KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards
PANEL MODERATORS:
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)
Kelly McKee, Vice President, Strategy & Transformation, Science 37; Co-Creator of the SCOPE Participant Engagement Award
David Sall, President & CEO, Patient Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award
Now in its 11th year, the Participant Engagement Award (PEA) recognizes innovation in how the industry engages with participants throughout clinical trial recruitment and retention. The award honors the values and accomplishments of Jerry Matczak, recipient of the inaugural 2017 award, whose legacy continues to inspire meaningful change in participant engagement. Submit your proposal: /participant-engagement-award
PANELISTS:
Andrea Bartucca, Director, Patient Recruitment and Retention, Clinical Operations, Eli Lilly and Co.
Sarah Bednarski, MS, Senior Director, Core Capabilities, Clinical Operations, BlueRock Therapeutics Savine DaCosta, Clinical Trial Access and Representation Site Lead, Biogen
Anita Difrancesco, Senior Vice President, Clinical Operations, Endeavor Biomedicines
Gretchen Goller, Head, Recruitment and Retention, Pfizer Inc.
April Lewis, Clinical Solutions, PatientPartner; Strategic Advisor, ZS
Wendy Lurrie, Acting Head of Comms, BestGuessistan
Adrienne Walstrum, Senior Director, Global Trial Optimization, Merck
Kate Wilson, Senior Director, Head of Global Clinical Trial Access & Representation, Biogen
4:35 Chairperson's Introduction: PwC Conference-Wide Welcome
Nisha Asher, Partner, Pharmaceuticals & Life Sciences, PwC
4:37 KEYNOTE FIRESIDE CHAT: From Reform to Implementation: FDA’s New Clinical Trial Innovation Office and Operation Trialblazer
Kevin Bugin, PhD, Associate Vice President, Head, Global Regulatory Policy and Intelligence, Amgen
Dianne Paraoan, Director, Office of Medical Policy, Office of New Drugs, CDER, FDA
FDA’s clinical-trial modernization agenda is moving from policy ambition to implementation. This plenary discussion will explore the new clinical-trial-innovation office being established within CDER’s Office of Medical Policy, Operation Trialblazer, and related FDA priorities. The conversation will focus on the office’s intended role, near-term priorities, opportunities to leverage existing industry capabilities, and what sponsors, sites, and research partners should anticipate as the work takes shape.
5:02 pm Chairperson's Introduction
Speakers to be Announced, ZS Associates
5:04 pm KEYNOTE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research
PANEL MODERATOR:
Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Patient recruitment remains one of the greatest barriers to faster clinical development. As traditional research models struggle to meet growing demand, sponsors, health systems, and academic medical centers are exploring new ways to integrate clinical research into routine care. This panel will examine how stronger partnerships between healthcare and research can expand patient access, improve enrollment, and accelerate the future of clinical development.
PANELISTS:
Nikki Amaratunge, Vice President, Clinical Development Operations, Head of Clinical Site Management, AbbVie, Inc.
Susan Griffing, Vice President, Late Development Oncology Clinical Operations, AstraZeneca
Elizabeth Rogers, Vice President, Head, R&D Clinical Operations, Portfolio Development, CSL Behring
Melinda Rottas, Vice President, Head of Optimization, Analytics & Recruitment Solutions, Pfizer Inc.
5:40 pm SCOPE's Kickoff Reception—Welcome to the Wild Wild West! (Sponsorship Opportunities Available)
Saddle up and kick off SCOPE the right way! Reunite with friends, make new connections, and soak up the Florida vibes at a Wild Wild West showdown you won't want to miss.
7:00 pm Close of Day
TUESDAY, MARCH 2, 2027
6:00 – 8:00 am Sunrise Yoga: In Gratitude for Clinical Research Participants (IN-PERSON ONLY)
Start your day with movement, mindfulness, and gratitude. Join us at sunrise for an all-levels yoga session honoring the invaluable contributions of clinical research participants. Led by a trained instructor, this restorative practice will focus on mindful movement, breath, and grounding—no experience necessary. Yoga begins at 6:30 am; mats and towels are provided. Stay afterward for a complimentary breakfast and fitness-inspired gift! Proceeds from this event help support CISCRP's mission. Registration Link Coming Soon!
6:30 am SCOPE's Morning Fun Run! (Sponsorship Opportunities Available)
COORDINATOR: Bridget Kotelly, Senior Director, Cambridge Healthtech Institute
Lace up and start your SCOPE day on the move! Join SCOPE's Coordinators for the 5K Rise and Shine Fun Run/Walk. Run, jog, walk, or chat your way through the course—ALL abilities are welcome. It's a fun, informal way to get moving and connect with fellow attendees. Full details to come, so don't forget your sneakers!
7:30 am Registration Open
7:30 am Get up & Go Specialty Coffee (Sponsorship Opportunities Available)
Start your day with a little extra fuel! Grab made-to-order specialty coffee and sweet bites, courtesy of our sponsors.
8:25 am Grab Your Seat: Early-Bird Seat Raffle & Prize Giveaway! * (Sponsorship Opportunity Available)
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
Arrive early, and you could leave a winner! Grab your seat and enter SCOPE’s Early Bird Seat Raffle for a chance to win an exciting prize. Don’t be late—*Must be present to win!
8:30 am Welcome to SCOPE 2027— Saddle Up for the Future of Clinical Trials
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
8:38 am Chairperson's Introduction
Speaker to be Announced, Medidata
8:40 am KEYNOTE FIRESIDE CHAT: The Other Side of Drug Development: A Pharma Leader's Journey as a Rare Disease Parent
Craig Lipset, Co-Chair, Decentralized Trials & Research Alliance (DTRA); Advisor, Buffalo Initiative
Casey McPherson, Founder & CEO, AlphaRose Therapeutics
Michelle Werner, Executive Vice President, President, North America, Ipsen, Rare Disease Mom and Advocate
For leaders who have spent their careers developing medicines, the experience of navigating a rare disease within their own family can bring an entirely different perspective to the urgency, complexity, and human impact of drug development. This fireside conversation will explore that intersection: what changes when an industry leader experiences drug development and clinical research as a parent, what the industry can learn from that perspective, and how it can inform the way we develop medicines and design clinical trials for patients and families.
9:05 am SCOPE’s Stretch Break & Annual T-Shirt Toss (Sponsorship Opportunity Available)
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
9:15 am KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible?
PANEL MODERATOR:
Micky Cohen-Wolkowiez, MD, PhD, Executive Director, i-Cubed, Duke Clinical Research Institute
Scientific advances, AI, modern trial designs, and evolving regulatory approaches are challenging long-held assumptions about the pace of clinical development. As pressure grows to bring new therapies to patients faster, the industry faces a fundamental question: can development be dramatically accelerated without compromising quality, safety, or scientific rigor? This panel will explore what it will take to fundamentally rethink the future of clinical development.
PANELISTS:
Meghana Chalasani, Associate Director for Clinical Trial Innovation, Office of New Drugs, FDA CDER
Zhanna Jumadilova, MD, Biopharmaceutical Physician Executive, Pragmatic Clinical Trials, R&D, Pfizer Inc.
Christoph Koenen, MD, Head of Clinical Development & Operations, Pharma R&D, Bayer
Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences
Michelle Werner, Executive Vice President, President, North America, Ipsen, Rare Disease Mom and Advocate
9:45 am Grand Opening Coffee & Refreshment Break in the Exhibit Hall (Sponsorship Opportunities Available)—Best of Show Voting Opens
Step into SCOPE’s one-of-a-kind exhibit hall! With 300+ leading clinical trial technology and service companies, it’s the place to discover new partners and reconnect with familiar ones. Cast your vote for SCOPE’s Best of Show, recharge with coffee, snap a photo, and don’t forget your comfy shoes—you’ll have miles to explore!
WEDNESDAY, MARCH 3, 2027
4:00 pm Organizer's Welcome Remarks
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
4:05 pm SCOPE Award Winners & Announcements (Sponsorship Opportunity Available)
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
4:10 pm Chairperson's Introduction: Building the Operating Models That Make Digital Transformation Possible
Rob Goodwin, COO, Parexel
4:12 pm KEYNOTE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient
PANEL MODERATOR:
Darren Weston, Head, Integrated Data Analytics and Reporting, Johnson & Johnson
Digital transformation is reshaping every stage of clinical development—from study design and protocol authoring to site activation, patient engagement, trial execution, data management, and AI-enabled decision-making. Yet technology alone is not enough. Achieving truly connected clinical trials requires interoperable systems, integrated workflows, modern operating models, and new ways of collaborating across sponsors, CROs, sites, and technology partners. This keynote panel will explore how leading organizations are building digitally enabled clinical trials that accelerate development while improving the experience for patients, sites, and study teams.
PANELISTS:
Michael Cantor, Vice President, Data Technology and Innovation, Global Development, Regeneron
Rachel Nering, Vice President, Head of Early Development and eDevelopment, Sanofi
Justine Rochon, Senior Vice President, Head of R&D Data and Quantitative Sciences, Takeda
Sammi Rui Tang, PhD, Senior Vice President & Global Head, Quantitative Sciences & Evidence Generation, Astellas Pharma, Inc.
4:42 pm Chairperson’s Closing Comments
Speaker to be Announced, Endpoint Clinical
4:45 pm SCOPE’s Booth Crawl (Sponsorship Opportunities Available) & Last Chance for Exhibit Viewing
5:45 pm Close of Day
5:45 pm SCOPE Out the Restaurants and Shops at Pointe Orlando, via Our Courtesy Shuttle* (Sponsorship Opportunities Available)
*Times subject to change.
THURSDAY, MARCH 4, 2027
THURSDAY CLOSING PLENARY: Reinventing R&D and Clinical Development
11:35 am Organizer's Welcome Remarks
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute
11:40 am Chairperson's Introduction (Sponsorship Opportunity Available)
11:42 am KEYNOTE PRESENTATION: AI and the R&D Revolution: Reinventing Drug Development from Discovery to Clinical Trials
Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences
Dan Sheeran, Vice President and General Manager, Healthcare and Life Science, AWS
AI is reshaping R&D from discovery through clinical development. This case study will explore how organizations are applying AI at scale to accelerate innovation, improve decision-making, and transform how new medicines are developed.
12:17 pm Chairperson's Introduction (Sponsorship Opportunity Available)
12:20 pm KEYNOTE INTERACTIVE PANEL: The New Clinical Development Operating Model
PANEL MODERATOR:
Kristi Koontz, Vice President, Global Study and Site Operations, Amgen
Clinical development organizations are being fundamentally redesigned. AI is accelerating change, but the transformation extends far beyond technology. Sponsors are rethinking organizational structures, governance, talent, strategic partnerships, outsourcing models, and decision-making to build faster, more agile, and more efficient development organizations. This keynote panel will bring together senior industry leaders to discuss how the next generation of clinical development organizations is taking shape—and what it will take to successfully lead through this transformation.
PANELISTS:
David Carruthers, PhD, Vice President, BioPharmaceuticals R&D Clinical Operations, AstraZeneca
Nick Hodges, Senior Vice President & Head, Clinical Development Operations & R&D Transformation Office, Ipsen
Henry Wei, Head of Development Innovation, Global Development, Regeneron
12:55 pm Sponsored Presentations (Opportunity Available)
1:25 pm Community Luncheon and Last Hurrah
Wrap up SCOPE with closing remarks and lunch, courtesy of our sponsors! Enjoy your lunch here with us or grab it to go as you head out for the day. The poolside is calling.
1:55 pm SCOPE Summit 2027 Adjourns